Not Available in Your Country



Introduced in Europe in 1975 by the Novartis Pharmaceuticals Corporation, clozaril was one of the first new drugs developed to treat schizophrenia in over 20 years. The pharmaceutical, which helps keep hallucinations, delusions, and hostility under control, did not enter the United States market until 14 years later and continues to be most heavily utilized in the Eastern Hemisphere.

Sorry, this page is not
available in your country.

This site uses cookies to enhance performance, analyze traffic, and for ads measurement purposes. If you do not change your web settings, cookies will continue to be used on this website. To learn more about how we use cookies on this website, and how you can restrict our use of cookies, please review our Cookie Policy.